FDA Plans eMDR System Updates

The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) plans to update the FDA’s electronic medical device reporting (eMDR) system to reflect updates to the FDA Form 3500A and other system enhancements. The FDA Form 3500A is...

FDA Clears GE Healthcare’s Deep Learning-Based MR Image Reconstruction

GE Healthcare has announced U.S. FDA 510(k) clearance of AIR Recon DL. “This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image...

GlobalData: Impact of COVID-19 on diagnostic imaging not as severe compared to other areas

The impact of COVID-19 on diagnostic imaging (DI) procedures will not be as severe compared to other therapy areas, such as aesthetics and dental, since only 38.7% of these procedures are elective and expected to drop due to the COVID-19 pandemic, according to...

FDA Approves Cerianna

PETNET Solutions Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of Zionexa SAS, have announced that the Food and Drug Administration (FDA) has approved Cerianna (fluoroestradiol F 18) injection for intravenous use. Cerianna...

Mini C-arm Product Spotlight: Mini C-arms Elevate Global Market

In today’s world, imaging systems are an essential technology in every hospital. Specialists in almost every field of surgery, including orthopedics and cardiology use C-arms for intraoperative imaging. The devices provide high-resolution X-ray images in real-time, thus allowing physicians to monitor progress at any point during the operation and immediately make necessary corrections. As a result, treatment results are better and patients recover faster.

In 2015, the global market for C-arms was estimated to be $1.7 billion. It is expected to exceed $2 million by the year 2021, growing at a compound annual growth rate (CAGR) of 3.2 percent during the forecast period of 2016-2021, according to Mordor Intelligence.

“C-arms are currently being used in several areas of medicine and their varied applications are only expected to increase over time,” Mordor Intelligence reports. “These factors, coupled with the increasing demand for health care infrastructure in developing and third-world countries, are driving the global C-arms market. On the other hand, the growing use of refurbished devices and the low replacement rates of C-arm systems are hindering market growth. With increasing focus on the portability of C-arms, there is a great market opportunity for companies producing mini C-arms. However, the increasing cost concerns in emerging economies resulting in increasing pricing pressures are presently the greatest challenge to be overcome in order to tap the full potential of this market.”

Research and Markets forecasts the global flouroscopy C-arms market to grow at a CAGR of 4.02 percent during the period 2016-2020.

“The development of the C-arms increases the emphasis on MIS (minimally invasive surgery), leading to reduced hospital stay. Therefore, there will be an increase in sales of C-arm equipment components in the hospital sector during the forecast period. The growing number of ambulatory surgical centers that perform numerous procedures is expected to further increase the demand for mobile C-arms in the market during the forecast period,” according to Research and Markets.

“One of the key trends for market growth will be effective results in combination of radiography and fluoroscopy systems,” Research and Markets adds. “The convergence of radiography and fluoroscopy systems is expected to have a positive impact on market growth during the forecast period. Recently, Philips Healthcare launched DuoDiagnost, combining radiography and fluoroscopy devices in one system. The combination of equipment offers better price-performance ratio, occupies less space, and can be used for several applications. Also, health care institutions can achieve a better return on investment by implementing such equipment.”

Persistence Market Research also predicts continued growth for the global C-arm market.

The global fluoroscopy and C-arms market is likely to exhibit a CAGR of 4.5 percent during the forecast period (2016–2024) with market revenue expected to increase to $4.2 billion by 2024, according to Persistence Market Research.

View the Product Gallery



Submit a Comment

Your email address will not be published. Required fields are marked *